Carcinoma, Hepatocellular Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Carcinoma, HepatocellularLiver NeoplasmsAdenocarcinoma+2 more
Shanghai Zhongshan Hospital17 enrolled1 locationNCT06794073
Recruiting
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Carcinoma, HepatocellularNon-Alcoholic Fatty Liver DiseaseCirrhosis, Liver+2 more
Ruijin Hospital20,000 enrolled1 locationNCT05870969